A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of AMG 592 in Healthy Japanese Participants

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
The primary objective of this study is to characterize the pharmacokinetics (PK) profile of a single dose of AMG 592 administered subcutaneously in healthy Japanese participants.
Epistemonikos ID: 0edfb00842f6e8a924787e076f4937b8bec693b8
First added on: Feb 19, 2024